Oct 28 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2025 Sep 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.77 2.67 5.50
(+3.7 pct) (+7.3 pct) (+3.7 pct)
Operating 422 mln 471 mln 850 mln
(-10.4 pct) (-8.9 pct) (+3.2 pct)
Recurring 427 mln 473 mln 850 mln
(-9.8 pct) (-9.8 pct) (+2.6 pct)
Net 306 mln 347 mln 600 mln
(-12.0 pct) (-6.0 pct) (-6.4 pct)
EPS 72.65 yen 82.54 yen 142.33 yen
Ann Div 35.00 yen 32.00 yen
-Q2 div NIL NIL
-Q4 div 35.00 yen 32.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T